SE7805707L - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
SE7805707L
SE7805707L SE7805707A SE7805707A SE7805707L SE 7805707 L SE7805707 L SE 7805707L SE 7805707 A SE7805707 A SE 7805707A SE 7805707 A SE7805707 A SE 7805707A SE 7805707 L SE7805707 L SE 7805707L
Authority
SE
Sweden
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
SE7805707A
Other languages
Swedish (sv)
Other versions
SE443716B (en
Inventor
P Cuatrecasas
S Moncada
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE7805707L publication Critical patent/SE7805707L/en
Publication of SE443716B publication Critical patent/SE443716B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7805707A 1977-05-20 1978-05-18 SETTING TO PREPARE A PHARMACEUTICAL PREPARATION FOR INHIBITING BLOOD SPOT SEGREGATION CONTAINING PROSTACYCLINE OR DIHYDROPROSTACYCLINE AND A PHOSPHODIESTERATION INHIBITOR SE443716B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79900777A 1977-05-20 1977-05-20
GB3526177 1977-08-23

Publications (2)

Publication Number Publication Date
SE7805707L true SE7805707L (en) 1978-11-21
SE443716B SE443716B (en) 1986-03-10

Family

ID=26262642

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7805707A SE443716B (en) 1977-05-20 1978-05-18 SETTING TO PREPARE A PHARMACEUTICAL PREPARATION FOR INHIBITING BLOOD SPOT SEGREGATION CONTAINING PROSTACYCLINE OR DIHYDROPROSTACYCLINE AND A PHOSPHODIESTERATION INHIBITOR

Country Status (8)

Country Link
JP (1) JPS542335A (en)
CH (1) CH643458A5 (en)
DE (1) DE2821737A1 (en)
FR (1) FR2390964A1 (en)
HU (1) HU180548B (en)
IT (1) IT1105506B (en)
NL (1) NL7805402A (en)
SE (1) SE443716B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3526362A1 (en) * 1985-07-19 1987-01-22 Schering Ag PROSTACYCLINE, YOUR ANALOGA OR PROSTAGLANDINE AND THROMBOXANANTAGONISTS FOR THE TREATMENT OF THROMBOTIC AND THROMBOEMBOLIC DISEASES
EP0299698B1 (en) * 1987-07-14 1992-09-09 Sankyo Company Limited Composition for forming antithrombotic medical appliances

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2

Also Published As

Publication number Publication date
JPS542335A (en) 1979-01-09
DE2821737A1 (en) 1978-11-30
NL7805402A (en) 1978-11-22
FR2390964A1 (en) 1978-12-15
CH643458A5 (en) 1984-06-15
FR2390964B1 (en) 1980-07-11
IT7849485A0 (en) 1978-05-22
SE443716B (en) 1986-03-10
IT1105506B (en) 1985-11-04
DE2821737C2 (en) 1988-05-19
HU180548B (en) 1983-03-28

Similar Documents

Publication Publication Date Title
SE7810591L (en) PHARMACEUTICAL COMPOSITIONS
FI783917A (en) AMINDERIVAT DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
SE7806691L (en) OSTOMIC COMPOSITION
BE872319A (en) PHARMACEUTICAL COMPOSITION
AR219293A1 (en) POLYESTER-POLYIMIDE COMPOSITIONS
RO78326A (en) ERBICIDA COMPOSITION
SE7711395L (en) PHARMACEUTICAL COMPOSITION
BE864359A (en) ANTIOESTROGEN PHARMACEUTICAL COMPOSITIONS
IT1095377B (en) PHARMACEUTICAL COMPOSITION
SE7801529L (en) PESTICID COMPOSITION
SE7803941L (en) ANTIOXIDING COMPOSITIONS
SE7803128L (en) MICROBICID COMPOSITION
FI783796A (en) FAERGFRAMKALLANDE COMPOSITION
IT7867018A0 (en) ANTI-ULCERA COMPOSITION
RO85275A (en) MILDINCIDA COMPOSITION
IT7849938A0 (en) PHARMACEUTICAL COMPOSITIONS
SE7801194L (en) CEREALIE COMPOSITION
SE7801368L (en) PESTICID COMPOSITION
SE7806441L (en) DRUG COMPOSITION
IT1101681B (en) FUNCICIDE COMPOSITION
SE7801430L (en) PEPSTICID COMPOSITION
FI773882A (en) COMPOSITION
SE7807376L (en) COMPOSITIONS
FI781435A (en) FUNGICID COMPOSITION
NL7801464A (en) PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7805707-2

Effective date: 19890525

Format of ref document f/p: F